Chart appears to be moving in the right direction over the past 2 weeks.
Management aren't ones to scream "new numbers" or "I dug a hole" every fortnight, so I suspect the next ASX notification will be the FY report due in ~3 weeks.
They have their crosshairs aimed at converting the Adheris pharmacy network across to digital programs.
30% should be live this quarter. If they can have over 50% by the end of the year, then critical mass suggests the remaining 50% or 13,000 pharmacies will follow soon after.
They have some solid supporters in their corner including HMS/Cotiviti who subscribed to the 1 : 2.5 entitlement offer in November.
Regal may not appear in the Top 20. It might be seen they pipped and flipped (pumped) their way out last year. It would be a sign of good things if PVM/Jencay held their shares tighter and longer, meaning less available on market - buyers would need wipe a few lines. Six figures is usually baited well above the share price of the day and is seen to mirror any upwards movement.
I assumed the API announcement might have moved the share price a bit more. MedAdvisor have (again) all 4x pharmaceutical wholesalers - EBOS, Sigma, Symbion and now API. API went AFK for a long time so to have all four, under long term contracts, shows local support for the technology.
With daily volume only a few hundred thousand units and single digit rises, we're still under the radar.
Add to My Watchlist
What is My Watchlist?
